Literature DB >> 31764264

Public Health Practice-Driven Research to Improve HIV Prevention in the United States.

Julia C Dombrowski1,2, Mary Irvine3, Denis Nash4,5, Graham Harriman3, Matthew R Golden1,2.   

Abstract

BACKGROUND: The evidence-practice gap in HIV prevention and the care continuum in the United States often reflects a mismatch between the perspectives of researchers and public health practitioners. The traditional research paradigm of sequential progress from efficacy research to implementation in practice and widespread scale-up is not well-aligned with the reality of health department program implementation.
SETTING: This article focuses on public health practice carried out by state and local health departments in the United States and the research intended to inform it. METHODS AND
RESULTS: In this narrative review, we discuss approaches to HIV prevention and care continuum research that are shaped by and responsive to public health practice implementation priorities and what is needed to promote productive and successful university-health department research partnerships. We review research methods of particular relevance to health departments to evaluate the effectiveness of HIV prevention and care continuum interventions and how these approaches diverge from traditional research approaches. Finally, we highlight the roles of federal agencies in supporting practice-driven HIV implementation research.
CONCLUSIONS: Health departments are key stakeholders, consumers, and generators of the evidence base for public health practice. High-impact research to improve HIV prevention and the care continuum is informed by health department priorities and current practice from the start. Long-term, equitable relationships between universities and health departments are crucial to advance practice-driven research.

Entities:  

Mesh:

Year:  2019        PMID: 31764264      PMCID: PMC6880801          DOI: 10.1097/QAI.0000000000002194

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  13 in total

Review 1.  Evaluating the public health impact of health promotion interventions: the RE-AIM framework.

Authors:  R E Glasgow; T M Vogt; S M Boles
Journal:  Am J Public Health       Date:  1999-09       Impact factor: 9.308

2.  Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact.

Authors:  Geoffrey M Curran; Mark Bauer; Brian Mittman; Jeffrey M Pyne; Cheryl Stetler
Journal:  Med Care       Date:  2012-03       Impact factor: 2.983

3.  Program Science: an initiative to improve the planning, implementation and evaluation of HIV/sexually transmitted infection prevention programmes.

Authors:  James F Blanchard; Sevgi O Aral
Journal:  Sex Transm Infect       Date:  2010-12-01       Impact factor: 3.519

Review 4.  Design and analysis of stepped wedge cluster randomized trials.

Authors:  Michael A Hussey; James P Hughes
Journal:  Contemp Clin Trials       Date:  2006-07-07       Impact factor: 2.226

5.  Using Registry Data to Construct a Comparison Group for Programmatic Effectiveness Evaluation: The New York City HIV Care Coordination Program.

Authors:  McKaylee M Robertson; Levi Waldron; Rebekkah S Robbins; Stephanie Chamberlin; Kate Penrose; Bruce Levin; Sarah Kulkarni; Sarah L Braunstein; Mary K Irvine; Denis Nash
Journal:  Am J Epidemiol       Date:  2018-09-01       Impact factor: 4.897

6.  A Cluster Randomized Evaluation of a Health Department Data to Care Intervention Designed to Increase Engagement in HIV Care and Antiretroviral Use.

Authors:  Julia C Dombrowski; James P Hughes; Susan E Buskin; Amy Bennett; David Katz; Mark Fleming; Angela Nunez; Matthew R Golden
Journal:  Sex Transm Dis       Date:  2018-06       Impact factor: 2.830

7.  Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study.

Authors:  Andrew E Grulich; Rebecca Guy; Janaki Amin; Fengyi Jin; Christine Selvey; Jo Holden; Heather-Marie A Schmidt; Iryna Zablotska; Karen Price; Bill Whittaker; Kerry Chant; Craig Cooper; Scott McGill; Barbara Telfer; Barbara Yeung; Gesalit Levitt; Erin E Ogilvie; Nila J Dharan; Mohamed A Hammoud; Stefanie Vaccher; Lucy Watchirs-Smith; Anna McNulty; David J Smith; Debra M Allen; David Baker; Mark Bloch; Rohan I Bopage; Katherine Brown; Andrew Carr; Christopher J Carmody; Kym L Collins; Robert Finlayson; Rosalind Foster; Eva Y Jackson; David A Lewis; Josephine Lusk; Catherine C O'Connor; Nathan Ryder; Emanuel Vlahakis; Phillip Read; David A Cooper
Journal:  Lancet HIV       Date:  2018-10-17       Impact factor: 12.767

8.  Regression discontinuity designs in epidemiology: causal inference without randomized trials.

Authors:  Jacob Bor; Ellen Moscoe; Portia Mutevedzi; Marie-Louise Newell; Till Bärnighausen
Journal:  Epidemiology       Date:  2014-09       Impact factor: 4.822

9.  A Hybrid III stepped wedge cluster randomized trial testing an implementation strategy to facilitate the use of an evidence-based practice in VA Homeless Primary Care Treatment Programs.

Authors:  Molly M Simmons; Sonya Gabrielian; Thomas Byrne; Megan B McCullough; Jeffery L Smith; Thom J Taylor; Tom P O'Toole; Vincent Kane; Vera Yakovchenko; D Keith McInnes; David A Smelson
Journal:  Implement Sci       Date:  2017-04-04       Impact factor: 7.327

10.  Short-term effectiveness of HIV care coordination among persons with recent HIV diagnosis or history of poor HIV outcomes.

Authors:  Denis Nash; McKaylee M Robertson; Kate Penrose; Stephanie Chamberlin; Rebekkah S Robbins; Sarah L Braunstein; Julie E Myers; Bisrat Abraham; Sarah Kulkarni; Levi Waldron; Bruce Levin; Mary K Irvine
Journal:  PLoS One       Date:  2018-09-24       Impact factor: 3.240

View more
  1 in total

1.  Now It's Time to Implement Social Capital and Sexually Transmitted Infection/HIV Interventions in the United States.

Authors:  Yusuf Ransome; Tiarney D Ritchwood
Journal:  Sex Transm Dis       Date:  2020-07       Impact factor: 3.868

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.